Feeds:
Posts
Comments

Posts Tagged ‘Diabetes’


Hi all,

Over the past few years I have been comuting to and from work by cycle which is about 4 miles so not too bad, well apart from when it is raining – cold – windy in fact I hate it (only joking).

20120531-205735.jpg

The one problem I have is my blood glucose levels plummet once iget to work or arrive home and I have tried numerous different products including dates and bananas which do definitely help. My problem is I am normally in a rush so prefer to pop something easy into my mouth and get going as soon as I can.

I am sure I am not the only person with Diabetes to have this issue and I have discovered jelly beans well Jelly Belly Beans which I must say do taste a little bit to nice as I struggle to put them down ha ha. A colleague of mine had read an article about people with Diabetes using jelly beans when running or swimming so I thought I would give it a try.

The great thing for me Is that each bean is approx 1g of carbohydrate and I tend to have between 10-15 beans before cycling which certainly does do the trick. What is do like is the fact they do not stay in my system for hours and hours but enough to cover my exercise which is usually about a 20 minute cycle. I have also tried Jelly Belly Sport Beans which do not taste quite so yummy but they do last far longer in your system and contain more carbohydrates per bean so better for longer bouts of exercise.

So down to my favourite flavours well all of them (Possibly not cinnamon). Cherry is so lovely, Top Banana is also a yummy bean and not forgetting Coconut.

Anyway I hope this has helped a little bit but if you have not tried Jelly Belly Beans before give them a try as they have helped me on more than one occasion but moderation is the key mmmmm.

Take care.

Andrew

http://www.mypump.co.uk
http://www.mypumpblog.com

Read Full Post »


I decided to attend the Input Roadshow held at Hilton Garden Inn – Luton on Saturday 14th April running from 1.00pm – 4.30pm and it was great to see Lesley and Anna from Input for a catch up.

20120502-123603.jpg

I was pleasantly surprised to see so many people with Diabetes attend to ask questions and see what Insulin Pumps are currently available. The companies who attended were Animas, Roche, Medtronic, Cellnovo and Advanced Therapeutics all showing off their latest pieces of Diabetes kit.

I arrived at 1.00pm and was greeted by the Input team that put this super event together so well done to the Input team for a great event. My main objective was to say hi to some of my contacts from the Insulin Pump companies and to see what new technology is available.

I am already very familiar with the Medtronic Veo and Animas Vibe which are both superb Insulin Pumps which offer integrated CGM but I didn’t get a chance to chat with the team from Advanced Therapeutics (sorry guys) which I was a little annoyed at but purely because they were busy and I run out of time unfortunately. I did however get to speak with Jill from Animas who I have met a few times and Justin from Medtronic who again I know very well so it was good to have a chat. I wanted to know more about the Accu-Chek Combo pump as i had not seen it before and how it works so spoke with Sue who also gave me a demo of the system which was great as everything you need can be done by the handheld BG Smart Meter very easily, I also like the software which gave some great reports and was easy to understand. Next I spoke with Carol from Cellnovo which is a new pump shortly being released and certainly looks amazing with its iPhone looking handset to the small patch pump, unfortunately I don’t know a huge amount about the Cellnovo pump as it is very new. Cellnovo is basically a patch pump with an amazing smart handset that can do everything from testing your BG with a built in blood glucose meter for test strips to monitoring exercise due to the patch pump having a built in accelerometer – wow.

My next task is to try and convince Cellnovo to let me try their pump so I can physically see how it works day to day as seeing it in your hand is different to sleeping, working or even excersining wearing the patch pump.

All in all a very enjoyable afternoon and superbly organised by Input so well done guys. Check out the Input web site for more info on forthcoming events as it is well worth a visit.

Andrew Borrett

My Pump
My Pump Blog

Read Full Post »


Hi,

I can’t believe I have already been on an Insulin Pump for 4 years which means my current pumps warranty is up for renewal and at the moment I use an Animas 2020 pump which has been great.

So I am currently using the New Animas Vibe and hope my blog shares some information that you may find useful.

The Animas Vibe insulin pump and CGM system combines state-of
the-art Dexcom G4 Sensing technology with high-performance Animas pumping. That means it gives you the features Animas® pumps are known for, like waterproof durability¥, fine-tuned dosing and a high-contrast, self-illuminating colour display. It’s also designed to streamline the whole CGM experience for you, while giving you a full-colour view of how your glucose is behaving.

Animas Vibe is designed to give you a more complete picture of your glucose*. In addition, its packed with a unique combination of features designed to help you perform at your best.

20120405-213828.jpg

I didn’t realise that the pump needed to be replaced after 4 years and was a little worried that it may not be funded again but my hospital at High Wycombe are very good and sorted everything out for me very easily. I had been speaking with Caroline and Jill from Animas about renewing my Animas 2020 pump and that I would like to try the Animas Vibe with CGM which they arranged for me.

20120405-214055.jpg

My day started at High Wycombe Diabetes Centre with Caroline, Jill and Una (DSN) on Monday 30th January 2012, as you can imagine I was very excited indeed. My old pump was really difficult to read the screen which had put me off the Animas pump but what I discovered was that the screen on my old pump had burnt out so needed replacing (That was a relief and of course Animas said they would replace it). We went through the functions of the new Animas Vibe pump which is pretty much the same as the Animas 2020 apart from the fact it has CGM so I already had a head start, I love how easy the Vibe is to use and the fact you have a nice clear colour screen especially when looking at the CGM trend graph as pictured above. The team at Animas and Una were really great and went through everything with me especially on how to use the CGM and inserting it, I am just so frustrated that I can’t get funding from the PCT for CGM.

The actual insertion of the sensor is very easy and didn’t really hurt at all but more of a scratch which I was pleasantly surprised with, the sensors are recommended to be placed on your tummy and not on your back which makes it easier to insert. I did however have an issue with the first sensor which must have hit a blood vessel as a couple of hours later the CGM alarmed to say it was not working, I spoke to Animas who said to change the sensor as when I was with them it looked as though it had possibly hit a small blood vessel. The setting up of the CGM was very easy once the sensor had been inserted and I actually managed easily on my own. The sensor last for 7 days and alarms to let you know once the 7 days has finished, I like the fact you can wear it for 7 days without changing. The second sensor I used went in perfectly and I had no problems at all and again was like a sharp scratch so no pain really.

In regards to the results given by the CGM please remember that the CGM is really to be used to give trends rather than exact blood glucose readings, at the end of the day pricking your finger is still the most accurate. My results compared to finger prick testing were out by quite a way to be honest (not all the time though) but I had been suffering with a nasty chest infection for over a week then travelled to Sweden for a few days, this probably didn’t help with the results so I do hope I get another chance to test the CGM now I am well – we shall see. I have one sensor left as of today Monday 27th Feb and plan to use this after my next Diabetes check up and I will then have used my months trial and can upload my results for my DSN.

So would I use CGM if it was funded by the PCT – yes most definately as it made me feel a lot less worried whilst travelling knowing it would alarm if my BG level was too low.

I hope this helps and hopefully I will get the chance to try some more sensors while I am feeling well but watch this space. Please email or comment if you have any questions at all.

Many thanks

Andrew Borrett
www.mypump.co.uk
www.mypumpblog.com

Read Full Post »


INPUT Insulin Pump Exhibitions 2012
Any (insulin pump) Question Answered

Have you heard about insulin pumps and wondered how to find out more about them? Do you have questions about what it’s like using a pump? Would you like to see in real life the makes and models of pumps you’ve heard about? Or do you have questions or concerns about NHS funding for pumps? Your chance to chat with pump users and pump company representatives about all these topics (and more) could be just around the corner at an INPUT roadshow!

Current Venues and Dates (further information on venues below). More dates and venues being added soon.

20120315-214310.jpg

Luton – 14th April 2012
Chester – 19th May 2012

Time: 1pm – 4:30pm
Who: open to all people with diabetes and their family members or carers who want to learn about the principles and practical aspects of pump therapy over a cup of tea or coffee.

We have invited the following companies to exhibit:

Abbott (Freestyle Navigator)
Advanced Therapeutics (Dana & Dexcom)
Animas
Cellnovo
Medtronic
Roche
Ypsomed (OmniPod)

****

Luton – Saturday 14th April 2012
Venue: Hilton Garden Inn Luton North Hotel, LU2 8DD

***

Chester – Saturday 19th May 2012
Venue: Macdonald New Blossoms Hotel, Chester, CH1 1HL.

Read Full Post »


‘Feet first’ for diabetes patients

As a new study highlights major variations in diabetes-related foot amputation rates, Barbara Young, chief executive of Diabetes UK, explains why action is needed to cut rates of preventable amputations.

If I were to tell you about a place where thousands of feet were amputated every year as a result of poor healthcare, you would assume I was talking about somewhere in the developing world.

Well you’d be wrong. The fact is that here in the UK, thousands of people with diabetes have amputations every year.

Not only does an amputation dramatically reduce quality of life, but the likelihood of dying within five years is greater than for breast, bowel or prostate cancer.

And yet an estimated 80% of the 5,000 diabetes-related amputations a year in England could be prevented through better healthcare and improved management of the condition.

The fact that so many people are needlessly having their feet amputated is a national disgrace. And yet despite the large numbers, awareness of the problem is worryingly low even among people with the condition.

But it does not have to be like this.

The scandal of preventable amputations is one we hope to bring to an end with our Putting Feet First campaign. Over the next five years, we want the number of amputations in people with diabetes to reduce by 50%.

Raising awareness of the issue will be a big part of this.

‘Insufficiently thorough’
The 2.8m people in the UK who have been diagnosed with diabetes should know how important it is to manage blood glucose levels, cholesterol and blood pressure well, as well as checking feet regularly and making sure shoes fit properly.

But they also need to know what healthcare you should expect – because all too often it falls short of what people are entitled to.

Firstly, everyone with diabetes should get an annual foot check.

These are important for identifying problems at an early stage, but many thousands of people are not getting them. And when they are being done, they are sometimes insufficiently thorough.

I have even heard of foot checks where the patient is not even asked to take their shoes and socks off!

Also, at the end of the check patients should be told what their risk status is, so if this does not happen then you should ask.

Secondly, if you have a foot ulcer then you need to be seen by a diabetes specialist foot care team as soon as possible.

It should certainly be within 24 hours, as an ulcer can deteriorate in a matter of hours.

Some areas are already doing well in terms of getting diabetes-related ulcers referred to these specialist teams within 24 hours.

But there are also poorly-performing areas where this does not happen.

Tragically, that omission can be the difference between someone keeping their foot and losing it.

If people with diabetes are not offered this level of care, they should insist on it and complain if they don’t get it.

But the point is that decent healthcare is something everyone should get as a matter of course.

For this to happen, we need to address the reason that large swathes of the country are doing so badly.

We know from speaking to health professionals that many of them are desperate to give people with diabetes the best possible foot care but feel unable to do so under the existing system.

This is why the government needs to show leadership on this issue by insisting that all areas of the country offer the same standard of care that is already available in the best areas at the moment and monitoring and managing standards to ensure that they are being delivered.

This greater political will is the only way to bring an end to the tragic postcode lottery of amputations and in doing so create an NHS that really does put feet first for people with diabetes.

Read Full Post »


SUNDAY, 26 FEBRUARY 2012
The Advanced Technologies and Treatments for Diabetes conference 2012 – a great blog from Anna at Insulin Independent

The 7th -10th February 2012 saw the arrival of the international event known as the Advanced Technologies and Treatments for Diabetes (ATTD) conference, which I was lucky enough to be able to attend as a representative of INPUT and funding from Dexcom to assist INPUT in the work they do. The ATTD is a worldwide conference where research outcomes at the very forefront of technological advance are presented. Being only 5 years old it is still in its fledgling years, but growing noticeably each year. Although I was not at last year’s event, I am informed that there were around 1000 attendees. This year, there were 1600 and I’m sure there are many more who would have attended given half a chance. It is aimed at diabetic professionals (or professional diabetics, in my case) mainly being consultants, nurses and diabetes educators, although the odd advocacy service pop up here and there too!
Being an insulin pump user, a diabetes advocate and a bit of an inquisitive old lass, it is always of great interest to me to see where this diabetes technology beast is heading. We hear terms like ‘Artificial Pancreas’ and ‘non-invasive glucose monitoring’ thrown about on an almost daily basis now and yet many people in the diabetic community feel these are creatures of myth and seem to hold a ‘that’ll be the day’ attitude towards them. So to be involved in a conference where this research is being presented was an honour and frankly, somewhat of an eye-opening occasion for me. .
Clearly it would be impossible to go through each of the presentations, symposiums and workshops in detail. Not in the least because my less than scientific mind would never be able to recall all the details for you. But perhaps giving you an idea of the things that caught my eye would be of use.

One of the stands in the exhibition which I kept circling in a slightly cautious way, was that of C8 Medisensors. In case you haven’t heard of them (I hadn’t), they are bringing to market a non-invasive glucose monitor that uses Raman Spectroscopytechnology which for those of you who don’t speak ‘medical journal’, is effectively a light that shines through the skin and identifies how many glucose particles there are in the interstitial fluid. Phew, mouthful ay. Well, according to early tests they are showing promising results, although the last test only involved 6 people. I would need to see a significant higher amount before I would be convinced it would rival the likes of Dexcom 7+ and Medtronic Enlite. Now we all remember the success of previous non-invasive systems such as the Glucowatch, the remnants of which remains burned on the skin cells of countless diabetics who had the misfortune of using it. But this was impressive. In its current form it is a bit on the ‘chunky’ side, and is held around the midriff with a tight neoprene band. But for those parents out there who hate the feeling of piercing their children’s skin with countless needles they have to face, I think this could be a contender. If, and only IF, they come good in clinical trials. Watch this space.

For quite some time I have been aware that in order to avoid post meal spikes I need to bolus 30 minutes before each meal, otherwise those spikes just creep in a couple of hours later. But we also know that each diabetic is different and we are told all the time to find our own way. So I was very interested in a lecture about bolus times in children using insulin pump therapy. In the results being demonstrated to the audience, the message was that 15 minutes was the optimum pre-meal bolus time to avoid those spikes. In addition to this the study, called “Fine Tuning of Insulin Pump Therapy in children with type 1 diabetes: The importance of bolus timing and type” demonstrated that making the most of dual wave boluses and separating correction boluses and meal boluses, would make all the difference. They found that with mediterranean food for example, boluses were split 70% straight away and 30% over 4 hours, while Pizza was 30% straight away and 70% over 6 hours. They also highlighted that the results of their study showed that when blousing for a meal, any correction bolus being included with the meal bolus, should be separated by 15 minutes, and that this would bring glucose down to normal via the fastest route. Fascinating stuff for me, someone who has always struggled to get my head about a dual waver

One of the key lectures for us to attend included INPUT’s very own Lesley Jordan taking to the stage. Lesley has been involved in a pioneering project to trial the Accu Chek Diaport, an intra-peritoneal (goes into the peritoneal cavity in the abdomen) infusion site which is permanently fixed (as long as the host wants it, that is). It is surgically implanted and regularly maintained and allows for insulin to be much faster acting (see number 3 on my list), removes the worry of hitting a bad site and means much better control. It may not be for everyone as it is surgically implanted but for those with site problems leading to frustration and poor control it provides a very useful tool in helping achieve control over their condition and maintain use of an insulin pump effectively. Lesley has been one of the Diaport ‘guinea pigs’ and thanks to feedback from her, the new and improved second generation is ready to launch.

There were also stands demonstrating the Omnipod, the Accu-Chek Combo, the Medtronic Veo and my particular favourite of the moment, the Cell-Novo. I had the chance to catch up with some old friends from Medtronic, meet new ones at Roche and Cell-Novo and had a chance to thank Dexcom for supporting INPUT and in a round about way, helped me attend such an inspiring event.

Read Full Post »


Sanofi to conduct a survey of parents who have teenagers and young adults with type 1 diabetes

20120118-204118.jpg

Do you have a son or daughter aged between 13 and 23 who has type 1 diabetes? Are you ever concerned about their health and diabetes management now that they are becoming more independent?

Sanofi is conducting a survey of parents of teenagers and young adults (aged between 13 and 23) who have type 1 diabetes to highlight any worries they may have for their children’s health and diabetes management. The survey will be used to support the launch of a new, blood glucose monitor (BGM).

Please find a link to the survey here: https://www.surveymonkey.com/s/flyingthenestfeature

If you have any questions, please get in contact with Claire Nicholson (tel: 020 7025 6524; email: claire.nicholson@redconsultancy.com)

Read Full Post »


A message from John Davis
Posted on January 6, 2012 by inputadmin www.input.me.org

John Davis

20120110-213301.jpg

I have been overwhelmed by the response to the announcement that I am to receive an MBE for services to diabetes in the New Year’s Honours list. I had no idea of the depth of feeling there is regarding my work with INPUT. It has been a humbling experience and I thank you all for your messages of congratulations.
Obviously it is a great honour and privilege to be recognised in such a way, and I am very proud to receive it. I believe that it is acknowledgment that, at last, insulin pump therapy has received the recognition that it deserves.

However, it could not have been achieved without the help and support of all of you out there in the “pump community.” There have been many who have contributed over the years and it is not possible to mention them all, but I must pay special tribute to Jackie Jacombs of the UK CWD Advocacy Group, who has been invaluable help for so long, and to Lesley Jordan, who has now taken over the reins of INPUT upon my retirement.

I would also like to give special thanks to;
Joan Everett, DSN at Royal Bournemouth Hospital. It was with Joan’s help that I started INPUT in 1998, back then there were only 180 pump users in the UK. Now there must be around 20,000.
Dr Fiona Campbell, who invited me to Leeds to make a presentation on insulin pumps to her Yorkshire colleagues. I took 3 children and their parents with me. I let the children tell their own story of life with a pump. It was after this presentation that Fiona decided to start using pumps in her clinic.

Finally, Prof John Pickup, a great man, who has not had the recognition he deserves for all his work in developing the pump. He gave me invaluable help in the early years.
It can be frustrating to be ahead of the curve. It took me several years of lobbying to get influential organisations and personalities in diabetes care in the UK to take pump therapy seriously. It is satisfying that we are now all going in the same direction.

Thank you

John Davis MBE

Read Full Post »


Claims of 24,000 ‘excess’ deaths from diabetes

(Read online)

Shock statistics for diabetes deaths have been widely reported

20120105-221753.jpg

As many as 24,000 people with diabetes are dying unnecessarily each year, many of the papers have reported today. This shock statistic was a conclusion from the National Diabetes Audit, the first ever report to look at deaths from the condition.

While this is a large number of deaths, it must be viewed in context – millions of people live with this potentially life-threatening long-term illness, yet it can be managed safely.

The National Diabetes Audit suggests that in England there are about 24,000 ‘excess deaths’ a year in people with diagnosed diabetes. This means that each year, around 24,000 more deaths occur among people with diabetes than would be expected to occur if their mortality risk was the same as that of the general population. A press release from the NHS Information Centre, which published the audit report, said these deaths could be avoided through better management of the condition.

What other risks did the National Diabetes Audit find?

The study found that the risk of death for a person with type 1 diabetes (where the insulin-producing cells of the body do not work at all) is 2.6 times higher than that of the general population. For people with type 2 diabetes (where the body does not produce enough insulin, or the body’s cells are not sensitive enough to insulin) it is 1.6 times higher.

In younger people, the difference in mortality rates is even bigger. For example, women between 15 and 34 years of age who have type 1 diabetes are nine times more likely to die than women in the general population, and women of this age with type 2 diabetes are six times more likely to die.

The report also found a strong link between deprivation and increased rates of early death. Among under-65s with diabetes, death rates among people from the most deprived backgrounds were double that of those from the least deprived. Death rates also vary according to where people live; London has the lowest mortality rates from both type 1 and 2 diabetes, while the highest mortality rates were in the north east of England.

The study’s lead clinician Dr Bob Young, consultant diabetologist and clinical lead for the National Diabetes Information Service, said, “For the first time we have a reliable measure of the huge impact of diabetes on early death. Many of these early deaths can be prevented. The rate of new diabetes is increasing every year. So, if there are no changes, the impact of diabetes on national mortality will increase. Doctors, nurses and the NHS working in partnership with people who have diabetes should be able to improve these grim statistics.”

What is the National Diabetes Audit?

The news is based on the National Diabetes Audit (NDA) Mortality Analysis 2007-2008. This report was prepared in partnership with various trusts, including The Healthcare Quality Improvement Partnership (HQIP), which promotes quality in healthcare, and the NHS Information Centre, the official source of health and social care data and information for England. The NDA covered four key components of the government’s National Service Framework (NSF) for Diabetes:

checking whether everyone with diabetes was diagnosed and recorded on a practice diabetes register
looking at whether those registered are receiving key elements of diabetes care (such as regular checks of blood glucose levels, or for protein in the urine)
looking at the proportion of people registered to have diabetes who achieve the treatment targets for glucose control, blood pressure and blood cholesterol, as defined by NICE
looking at the rates of acute and long-term complications of people with diabetes, including deaths from the condition, the focus of the current report
As part of this GP audit, all primary care trusts contributed data from 5,359 GP practices on 1.4 million people with diabetes. This figure represents 68% of the 2.1 million people estimated to have diabetes in England in 2007-2008 (the participation rate). The current analysis focuses on mortality from the condition, and has therefore also linked data from the NDA to formal death notifications through the NHS Information Centre Medical Research Information Service (MRIS) in order to include data for those people with diabetes not included in the GP audit.

What was the report’s main finding?

By following up the ‘cohort’ of 1.4 million people with diabetes over the next year, the researchers found 49,282 deaths. As the ‘participation rate’ (see above) was 68%, taking the estimated prevalence of diabetes in England, it was estimated that the total annual number of deaths of people with diabetes was between 70,000 and 75,000. This represents about 15-16% of the 460,000 deaths that occur annually in England.

Researchers estimated that in total there were about 16,000 more deaths among people with diabetes than would been expected if their mortality risk was the same as the general population. By linking these results to records of national death certificates (in order to include people with diabetes who did not participate in the audit) they estimated 24,000 excess deaths each year in people with diabetes.

The risk of death for patients with type 1 diabetes was estimated to be 2.6 times higher than that of the general population, and for people with type 2 diabetes the risk was estimated to be 1.6 times higher. Across the country there were variations in mortality, from 1,852 deaths out of 100,000 people with type 1 diabetes in London to a high of 2,351 out of 100,000 in the northeast. For type 2 diabetes the figures ranged from 1,246 out of 100,000 in London to 1,668 out of 100,000 in the northeast.

Why are so many people dying of diabetes?

The analysis itself did not look at the specific causes of death among people with diabetes. However, it is widely recognised that without proper management of this condition, there is a higher risk of death from several causes including critically high or low blood sugar, heart failure or kidney failure.

Diabetes is a long-term condition that affects the body’s ability to process glucose (sugar). Normally the amount of glucose in the blood is controlled by the hormone insulin, which helps break it down to produce energy. In people with diabetes, there is either not enough insulin to process the glucose or the body’s cells do not respond appropriately to the insulin produced. This results in glucose levels building up in the blood.

There are two types of diabetes: type 1 and 2. People with type 1 diabetes do not produce any insulin. People with type 2 diabetes do not make enough insulin, or the body’s cells are not sensitive enough to insulin. Having either type puts people at increased risk of several serious complications, including heart disease and stroke, circulation problems, nerve damage, foot ulcers, blindness and kidney damage.

It is important to note that this audit measured deaths among people with diabetes – it did not show whether diabetes caused their deaths. For example, diabetes is a risk factor for cardiovascular disease such as heart attack or stroke. Also, other cardiovascular risk factors that often co-exist in people with diabetes, such as overweight or obesity or high blood pressure. It is not possible to tell the direct cause of death from this data.

How is diabetes usually managed?

Diabetes management aims to keep blood glucose levels as normal as possible. People with type 1 diabetes need to have daily injections (or administration by pump) of insulin.

In people with type 2 diabetes, management depends upon the severity of the condition. A healthier diet and lifestyle alone can sometimes control the condition in people with early stage disease, although most people with type 2 eventually need to take medication to control their blood sugar. Some people with type 2 diabetes may also eventually need to take insulin. Medication may also be needed to reduce other associated risk factors for cardiovascular disease. For example, medications to reduce high blood pressure or control cholesterol.

Self-management of this condition is also crucial. People with diabetes need to be aware of and monitor blood glucose levels, maintain a healthy weight, eat a balanced diet, avoid smoking and have regular health checks.

How can these deaths be prevented?

Experts agree that people with diabetes can live long and healthy lives and reduce their risks of complications through appropriate self-management, as outlined above.

The charity Diabetes UK says that people with diabetes can sometimes feel overwhelmed with information about all the healthcare they require. Diabetes UK has drawn up a checklist of 15 ‘healthcare essentials’ to help people understand what care they should receive to reduce the risk of complications. These are:

get your blood glucose levels measured at least once a year
have your blood pressure measured at least once a year
have blood fats (cholesterol) measured every year
have your eyes screened for signs of eye damage (retinopathy) every year
have your legs and feet checked annually
have your kidney functions monitored annually
have your weight checked and your waist measured
get support if you are a smoker on how to quit
receive care planning to meet your individual needs
attend an education course to help you understand and manage your diabetes
receive specialist paediatric care if you are a child or young person
receive high quality diabetes care if admitted to hospital
get information and specialist care if you are planning to have a baby
see specialist diabetes healthcare professionals to help you manage your condition
get emotional and psychological support from specialist healthcare professionals
Not every healthcare essential may apply to children with diabetes who may have different requirements.

Do I need to worry about this if I have diabetes?

The figures are alarming but they do highlight the need to make people with diabetes aware of the importance of self-management and of obtaining the level of healthcare they require to help them manage their condition. With the right care and support, people with diabetes can go on to live long and healthy lives.

If you have diabetes, key ways to delay or prevent complications include:

maintaining a healthy weight by eating a balanced diet and taking regular physical exercise
not smoking
checking your feet every day
having regular check-ups with your diabetes care team.
Links to the headlines

24,000 diabetes deaths a year ‘could be avoided’. BBC News, December 14 2011

Diabetes report reveals 24,000 a year die from condition avoidably early. Guardian, December 14 2011

Up to 24,000 Britons with diabetes dying unnecessarily due to poor care. Daily Mirror, December 14 2011

Simple rules to beat diabetes. Daily Express, December 14 2011

Further reading

NHS Information Centre: National Diabetes Audit Mortality Analysis 2007-2008 (PDF 1.3Mb)

Press releases
NHS Information Centre: Up to 24,000 people with diabetes suffer an avoidable death in England each year. December 14 2011

Diabetes UK: Report shows each year 24,000 people in England with diabetes suffer avoidable death. December 14 2011

Read Full Post »


Hi all

I just wanted to wish everyone a very Happy and safe New Year.

Thank you all so much for your kind words and support through 2012 which has helped my sites grow. I will continue to update the sites with info to the best of my knowledge, please let me know if you have any info or articles you wish to include ?

Kindest regards

Andrew Borrett

http://www.mypump.co.uk
http://www.mypumpblog.com
Twitter @MyPump1

Read Full Post »

« Newer Posts - Older Posts »